Human Immunology News Volume 13.10 | May 27 2025

    0
    2







    2025-05-27 | HIN 13.10


    Human Immunology News by STEMCELL Technologies
    Vol. 13.10 – 27 May, 2025
    TOP STORY

    Antisense to Human CD39 Dysregulates Immune Metabolism in Inflammatory Bowel Disease

    Researchers investigated how CD39-AS affects the function of Tregs and Th17 cells in healthy subjects and inflammatory bowel disease patients.
    [Cellular & Molecular Immunology]

    AbstractGraphical Abstract
    PUBLICATIONSListed by the impact factor of the journal

    Clemastine Fumarate Accelerates Accumulation of Disability in Progressive Multiple Sclerosis by Enhancing Pyroptosis

    Investigators identified pyroptosis as a likely mechanism of central nervous system injury underlying progressing independently of relapse activity even outside of clemastine toxicity.
    [Journal of Clinical Investigation]

    Full Article

    IL-32-Producing CD8+ Memory T Cells Define Immunoregulatory Niches in Human Cutaneous Leishmaniasis

    Scientists identified IL-32–expressing CD8+ memory T cells and Tregs as key components of the indoleamine 2,3-dioxygenase 1/programmed death–ligand 1 niche in Sri Lankan patients with cutaneous leishmaniasis and in patients with distinct forms of dermal leishmaniasis in Brazil and India.
    [Journal of Clinical Investigation]

    Full ArticleGraphical Abstract

    Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair Proficient Colorectal Cancer

    Researchers investigated whether lymphocyte-activation gene 3 (LAG-3)/PD-1 inhibition would improve clinical outcomes in a mismatch repair proficient colorectal cancer subset.
    [Clinical Cancer Research]

    Abstract

    Reactivating cGAS-STING Signaling by Targeting SOS1 Enhances Antitumor Immunity in NRAS-Mutant Tumors

    Analysis of RNA-sequencing data revealed a downregulation of the type I interferon response in NRAS-mutant tumors compared with NRAS wild-type tumors, which is associated with poor prognosis in NRAS-mutant melanoma.
    [Cancer Research]

    Abstract

    IGM-7354, an Immunocytokine with IL-15 Fused to an Anti-PD-L1 IgM, Induces NK, and CD8+ T Cell-Mediated Cytotoxicity of PD-L1 Positive Tumor Cells

    Scientists reported an immunocytokine, IGM-7354, which was designed to bind multiple PD-L1 receptors while trans-presenting a single IL-15/IL-15Rα complex on the joining chain to IL-15Rβγ-expressing cytotoxic natural killer and CD8+ T cells.
    [Cancer Immunology Research]

    Abstract

    Cell Therapy with Human IL-10-Producing ILC2s Enhances Islet Function and Inhibits Allograft Rejection

    Investigators explored whether group 2 innate lymphoid cells (ILC2s) that produce IL-10 could enhance islet function and prevent allograft rejection in humanized mouse models of islet transplantation.
    [American Journal of Transplantation]

    Full Article

    Inflammation and IL-4 Regulate Parkinson’s and Crohn’s Disease Associated Kinase LRRK2

    Scientists described the development of a flow cytometry-based assay to assess leucine-rich repeat protein kinase 2 (LRRK2) activity in individual cells and the generation of an EGFP-Lrrk2 knock-in reporter mouse to analyse cell-specific LRRK2 expression.
    [EMBO Reports]

    Full ArticleGraphical Abstract

    KRAS May Facilitate Transformation of Chronic Lymphocytic Leukemia to Histiocytic Sarcoma with Indeterminate Dendritic Cell Features

    Researchers investigated the molecular mechanism underlying transformation of chronic lymphocytic leukemia to histiocytic sarcoma with indeterminate dendritic cell features.
    [American Journal of Clinical Pathology]

    Abstract
    REVIEWS

    The Inactive X Chromosome: A Genetic Driver of Female-Biased Rheumatic Autoimmune Disorders?

    The authors focus on the experimental evidence suggesting that expression of X-linked genes due to dysregulation in X chromosome inactivation maintenance could contribute to the female predisposition for autoautoimmunity.
    [European Journal of Immunology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Brain Cancer Canada Awards $68,000 Research Grant for Clinical Trial of Anti-Cancer Vaccine Targeting DIPG, the Most Aggressive Pediatric Brain Cancer

    Brain Cancer Canada awarded $68,000 for an innovative research initiative led by Dr. Aru Narendran and Dr. Patrick Sipila, at The University of Calgary and Alberta Children’s Hospital.
    [Brain Cancer Canada (Globe Newswire)]

    Press Release
    FEATURED EVENT

    New Approaches and Concepts in Microbiology

    June 24-27, 2024
    Heidelberg, Germany and Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scientist – Cancer Immunology

    King’s College London – London, England, United Kingdom

    Postdoctoral Research – Wound Healing and Regulatory RNA

    Karolinksa Institutet – Solna, Sweden

    Postgraduate Researcher – Infection, Immunity, & Inflammation

    University of Glasgow – Glasgow, Scotland

    Assistant Professor – Immunology

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Senior Postdoctoral Fellow / Research Associate – Molecular Oncology

    Fondazione per l’Istituto oncologico di ricerca IOR – Bellinzona, Switzerland

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2